Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Clinical trial NCT00501332 · UNKNOWN

Trial details

NCT number: NCT00501332
Sponsor: Maxygen Holdings Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-Induced Neutropenia Breast Cancer

Start date: 2007-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.